U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07412496) titled 'A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy' on Jan. 26.

Brief Summary: This is a multicenter, double-masked study to evaluate the use of Topical Ocular BL1332 for the management of post-operative pain after Photorefractive Keratectomy (PRK) surgery.

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Pain, Postoperative

Intervention: DRUG: Topical Ocular BL1332 low dose

Administered 5 times a day

DRUG: Topical Ocular BL1332 high dose

Administered 5 times a day

DRUG: BL1332 Vehicle ophthalmic vehicle

Administered...